Spinal activation of alpha7-nicotinic acetylcholine receptor attenuates posttraumatic stress disorder-related chronic pain via suppression of glial activation. (6th March 2017)

• Record Type: Journal Article
• Authors: Sun, Rao; Zhang, Wei; Bo, Jinhua; Zhang, Zuoxia; Lei, Yishan; Huo, Wenwen; Liu, Yue; Ma, Zhengliang; Gu, Xiaoping
• Is Part Of: Neuroscience. Volume 344(2017)
• Page Start: 243
• Page End: 254
• Publication Date: 2017-03-06
• Subjects: α7 nAChR alpha-7 nicotinic acetylcholine receptor -- AKT protein kinase B -- ANOVA analysis of variance -- CNS central nervous system -- CREB cAMP response element-binding protein -- DMSO dimethylsulfoxide -- ELISA enzyme-linked immuno sorbent assay -- GFAP glial fibrillary acidic protein -- IL-1β interleukin-1β -- IL-6 interleukin-6 -- JAK2 Janus kinase 2 -- LPS lipopolysaccharides -- MLA methyllycaconitine -- NF-κB nuclear factor kappa B -- PBS phosphate buffer solution -- PI3K phosphatidylinositol-3 kinase -- PTSD posttraumatic stress disorder -- PWMT paw withdrawal mechanical threshold -- SIH stress-induced hyperalgesia -- SPS single prolonged stress -- TNF-α tumor necrosis factor α; Alpha7-nicotinic acetylcholine receptor -- Posttraumatic stress disorder -- Stress-induced hyperalgesia -- Microglia -- Astrocyte -- Inflammation; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2016.12.029
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: SPS exposure produced persistent mechanical allodynia. SPS induced glial activation and accumulation of pro-inflammatory cytokines in spinal cord. Activation of spinal α7 nAchR attenuated SPS-evoked mechanical allodynia. Activation of spinal α7 nAchR suppressed SPS-induced pro-inflammatory activation of spinal glia. Abstract: The high prevalence of chronic pain in posttraumatic stress disorder (PTSD) individuals has been widely reported by clinical studies, which emphasized an urgent need to uncover the underlying mechanisms and identify potential therapeutic targets. Recent studies suggested that targeting activated glia and their pro-inflammatory products may provide a novel and effective therapy for the stress-related pain. In this study, we investigated whether activation of alpha-7 nicotinic acetylcholine receptor (α7 nAChR), a novel anti-inflammatory target, could attenuate PTSD-related chronic pain. The experiments were conducted in a rat model of single prolonged stress (SPS), an established model of PTSD-pain comorbidity. We found that SPS exposure produced persistent mechanical allodynia. Immunohistochemical and enzyme-linked immuno sorbent assay analysis showed that SPS also induced elevated activation of glia cells (including microglia and astrocytes) and accumulation of pro-inflammatory cytokines in spinal cord. In another experiment, we found that intrathecal injection of PHA-543613, a selective α7 nAchR agonist, attenuated the SPS-evoked allodynia in a dose dependent manner. However, this anti-hyperalgesic effect was blocked by pretreatment with methyllycaconitine (MLA), a selective α7 nAchR antagonist. Further analyses showed that PHA-543613 suppressed SPS-induced spinal glial activation and SPS-elevated spinal pro-inflammatory cytokines, and these were abolished by MLA. Taken together, the present study showed that spinal activation of α7 nAChR by PHA-543613 attenuated mechanical allodynia induced by PTSD-like stress, and the suppression of spinal glial activation may underlie this anti-hyperalgesic effect. Our study demonstrated the therapeutic potential of targeting α7 nAChR in the treatment of PTSD-related chronic pain.